Company news

XOMA Royalty Corporation news in 2023

XOMA Royalty Corporation's news releases, calls and decks from 2023, newest first.

View company

XOMA Reports Third Quarter 2023 Financial Results and Highlights Upcoming Events Expected to Drive Shareholder Value

November 6, 2023

XOMA Earns $5 Million Milestone Upon FDA Acceptance of Day One’s Tovorafenib NDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)

October 30, 2023

XOMA Reports Second Quarter 2023 Financial Results and Provides Update on its Royalty Monetization Strategy

August 7, 2023

XOMA Acquires Royalty and Milestone Economics to Phase 3 First-In-Class Orphan Disease Asset for Niemann-Pick Disease Type C (NPC) and Phase 2 Oncology Asset

June 21, 2023

XOMA Declares Quarterly Preferred Stock Dividends

June 19, 2023

XOMA Reports First Quarter 2023 Financial Results and Provides Update on the Acceleration of its Differentiated Royalty Monetization Strategy

May 8, 2023

XOMA Acquires Cashflow-Generating Asset for its Royalty and Milestone Portfolio

March 29, 2023

XOMA Reports Full-Year 2022 Financial Results and Provides Update to the Acceleration of its Differentiated Royalty Monetization Strategy

March 8, 2023

XOMA Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 5, 2023

New Executive Leadership Team Appointed to Accelerate XOMA’s Differentiated Royalty Monetization Strategy

January 3, 2023

Decks in 2023